The antinociceptive effect of intrathecal kynurenic acid and its interaction with endomorphin-1 in rats

被引:18
|
作者
Kekesi, G
Joo, G
Csullog, E
Dobos, I
Klimscha, W
Toth, K
Benedek, G
Horvath, G
机构
[1] Univ Szeged, Fac Med, Dept Physiol, H-6701 Szeged, Hungary
[2] Univ Vienna, Dept Anesthesiol & Intens Care, Vienna, Austria
[3] Bacs Kiskun Cty Hosp, Dept Orthoped, Kecskemet, Hungary
[4] Univ Szeged, Fac Hlth Sci, Dept Physiotherapy, H-6701 Szeged, Hungary
基金
匈牙利科学研究基金会;
关键词
antinociception; endogenous ligand; opioid; intrathecal infusion; NMDA receptor antagonist; paw withdrawal test;
D O I
10.1016/S0014-2999(02)01787-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Kynurenic acid as an endogenous ligand antagonizes all types of ionotropic glutamate receptors, with preferential affinity for the glycine-binding site of the N-methyl-D-aspartate (NMDA) receptor. The purpose of the present study was to investigate the antinociceptive potency of continuously administered kynurenic acid on carrageenan-induced thermal hyperalgesia by means of a paw withdrawal test in awake rats. The possible interaction between kynurenic acid and the endogenous L-opioid receptor agonist peptide, endomorphin-1, was examined in the same set-up. Kynurenic acid at the higher doses (1-4 mug/min) significantly decreased the thermal hyperalgesia and increased the paw withdrawal latencies on the non-inflamed side. These doses were also associated with motor impairment on both sides. Low doses of kynurenic acid (0.01 - 0.1 mug/min) potentiated, but did not prolong, the antinociceptive effect of endomorphin- 1 (0.1 - 1 mug/min) on the inflamed side. There was no sign of motor impairment during the combined treatment. These findings demonstrate that the combination of low doses of these two endogenous ligands provides effective and well-controlled antinociception without side effects. (C) 2002 Published by Elsevier Science B.V.
引用
收藏
页码:93 / 96
页数:4
相关论文
共 50 条
  • [1] Antinociceptive effect of continuous intrathecal administration of endomorphin-1
    Csullog, E
    Joo, G
    Toth, G
    Dobos, D
    Benedek, G
    Horvath, G
    [J]. PAIN, 2001, 94 (01) : 31 - 38
  • [2] Antinociceptive effects of intrathecal endomorphin-1 and-2 in rats
    Horvath, G
    Szikszay, M
    Tömböly, C
    Benedek, G
    [J]. LIFE SCIENCES, 1999, 65 (24) : 2635 - 2641
  • [3] Antinociceptive effects of intrathecal endomorphin-1 and-2 in rats
    Szikszay, M
    Horvath, G
    Joo, G
    Benedek, G
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 201 - 202
  • [4] The Peripheral Antinociceptive Effects of Endomorphin-1 and Kynurenic Acid in the Rat Inflamed Joint Model
    Mecs, Laszlo
    Tuboly, Gabor
    Nagy, Endre
    Benedek, Gyorgy
    Horvath, Gyongyi
    [J]. ANESTHESIA AND ANALGESIA, 2009, 109 (04): : 1297 - 1304
  • [5] Electroacupuncture potentiates the antinociceptive effect of intrathecal endomorphin-1 in the rat formalin test
    Hao, S
    Takahata, O
    Iwasaki, H
    [J]. NEUROSCIENCE LETTERS, 2000, 287 (01) : 9 - 12
  • [6] Comparison of the effect of intrathecal endomorphin-1 and endomorphin-2 on spinal cord excitability in rats
    Grass, S
    Xu, IS
    Wiesenfeld-Hallin, Z
    Xu, XJ
    [J]. NEUROSCIENCE LETTERS, 2002, 324 (03) : 197 - 200
  • [7] Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats
    Hao, SL
    Mamiya, K
    Takahata, O
    Iwasaki, H
    Mata, M
    Fink, DJ
    [J]. ANESTHESIA AND ANALGESIA, 2003, 96 (04): : 1065 - 1071
  • [8] Antinociceptive interaction between anandamide and endomorphin-1 at spinal level
    Horvath, G.
    Tuboly, G.
    Benedek, G.
    [J]. ACTA PHYSIOLOGICA HUNGARICA, 2007, 94 (04) : 353 - 354
  • [9] The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats
    Horvath, G
    Joo, G
    Dobos, I
    Klimscha, W
    Toth, G
    Benedek, G
    [J]. ANESTHESIA AND ANALGESIA, 2001, 93 (04): : 1018 - 1024
  • [10] The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse
    Tseng, LF
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 89 (03): : 216 - 220